| abstract |
The present invention provides, among other things, methods and compositions for treating muscular dystrophy, especially Duchenne muscular dystrophy (DMD). In some embodiments, the method according to the present invention comprises administering to a subject suffering from or susceptible to DMD an effective amount of a recombinant pol statin fusion protein to a subject suffering from DMD such that the intensity, severity, or frequency of at least one symptom or characteristic of the DMD is decreased, Lt; / RTI > |